These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 15106748)

  • 41. Reduction in surgical ischemic-reperfusion injury with adenosine and nitric oxide therapy.
    Vinten-Johansen J; Zhao ZQ; Sato H
    Ann Thorac Surg; 1995 Sep; 60(3):852-7. PubMed ID: 7677546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction.
    Favre J; Musette P; Douin-Echinard V; Laude K; Henry JP; Arnal JF; Thuillez C; Richard V
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1064-71. PubMed ID: 17332486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of polymorphonuclear neutrophils in myocardial damage during ischemia and reperfusion.
    Wysocki H
    Arch Immunol Ther Exp (Warsz); 1992; 40(1):49-53. PubMed ID: 1485826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelial progenitor cells: more than an inflammatory response?
    Rabelink TJ; de Boer HC; de Koning EJ; van Zonneveld AJ
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):834-8. PubMed ID: 15001453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complement, neutrophils and free radicals: mediators of reperfusion injury.
    Lucchesi BR
    Arzneimittelforschung; 1994 Mar; 44(3A):420-32. PubMed ID: 8185717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transient and reversible deoxyribonucleic acid damage in human left ventricle under controlled ischemia and reperfusion.
    Corbucci GG; Perrino C; Donato G; Ricchi A; Lettieri B; Troncone G; Indolfi C; Chiariello M; Avvedimento EV
    J Am Coll Cardiol; 2004 Jun; 43(11):1992-9. PubMed ID: 15172403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms by which low-intensity ultrasound improve tolerance to ischemia-reperfusion injury.
    Bertuglia S
    Ultrasound Med Biol; 2007 May; 33(5):663-71. PubMed ID: 17383799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role of the granulocytes in ischemic cardiopathy].
    Mazzone A; Pasotti D; Mazzucchelli I; Fossati G; Ricevuti G
    Recenti Prog Med; 1994; 85(7-8):397-406. PubMed ID: 8079042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathophysiology of ischaemia-reperfusion injury.
    Carden DL; Granger DN
    J Pathol; 2000 Feb; 190(3):255-66. PubMed ID: 10685060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxidative stress and ischemic myocardial syndromes.
    Misra MK; Sarwat M; Bhakuni P; Tuteja R; Tuteja N
    Med Sci Monit; 2009 Oct; 15(10):RA209-219. PubMed ID: 19789524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs.
    Zhang HX; Zang YM; Huo JH; Liang SJ; Zhang HF; Wang YM; Fan Q; Guo WY; Wang HC; Gao F
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):306-13. PubMed ID: 17204910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultrastructural evidence of myocardial alterations in the course of heterotopic heart transplantation.
    Ibba Manneschi L; Formigli L; Tani A; Perna AM; Zecchi Orlandini S
    J Submicrosc Cytol Pathol; 1996 Jul; 28(3):401-8. PubMed ID: 8765582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of myocardial nitric oxide in diabetic ischemia-reperfusion dysfunction: studies in mice with myocyte-specific overexpression of endothelial nitric-oxide synthase.
    Pozo-Navas B; Stessel H; Wölkart G; Brunner F
    J Pharmacol Exp Ther; 2006 Nov; 319(2):729-38. PubMed ID: 16857730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Primary and secondary prevention of coronary heart disease: smoking].
    Meinertz T; Heitzer T
    Z Kardiol; 2002; 91 Suppl 2():3-11. PubMed ID: 12436760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide.
    Hobbs A; Foster P; Prescott C; Scotland R; Ahluwalia A
    Circulation; 2004 Sep; 110(10):1231-5. PubMed ID: 15337698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postconditioning: reduction of reperfusion-induced injury.
    Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 2006 May; 70(2):200-11. PubMed ID: 16545349
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repetition of ischemic preconditioning augments endothelium-dependent vasodilation in humans: role of endothelium-derived nitric oxide and endothelial progenitor cells.
    Kimura M; Ueda K; Goto C; Jitsuiki D; Nishioka K; Umemura T; Noma K; Yoshizumi M; Chayama K; Higashi Y
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1403-10. PubMed ID: 17446439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in P-selectin expression on cardiac microvessels in blood-perfused rat hearts subjected to ischemia-reperfusion.
    Chukwuemeka AO; Brown KA; Venn GE; Chambers DJ
    Ann Thorac Surg; 2005 Jan; 79(1):204-11. PubMed ID: 15620944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oncostatin-M in myocardial ischemia/reperfusion injury may regulate tissue repair.
    Gwechenberger M; Moertl D; Pacher R; Huelsmann M
    Croat Med J; 2004 Apr; 45(2):149-57. PubMed ID: 15103750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.